Groundbreaking Alzheimer’s Trial Targets Prevention in At-Risk Individuals

In a significant development in the fight against Alzheimer's disease, an experimental drug is set to be tested on healthy, middle-aged individuals identified as being at higher risk for the condition. This groundbreaking clinical trial aims to explore whether early intervention can halt the progression of Alzheimer's before any dementia symptoms manifest.

The initiative is being spearheaded by an NHS trust as part of a broader international study focused on preventing dementia. Participants will include those without any existing memory loss, highlighting a proactive approach to addressing this widespread health concern.

Source: www.theguardian.com